GSTM1 and GSTT1 null polymorphisms and risk of salivary gland carcinoma

International Journal of Clinical and Experimental Medicine

Volumn 2, Issue 1, 2009, Pages 68-75

  Kondo, Sayaka ^a,b   Sturgis, Erich M ^a   Li, Fanglin ^a,c   Wei, Qingyi ^a   Li, Guojun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS DENTAL BRANCH AT HOUSTON   (United States)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Genetic susceptibility; Glutathione S transferase (GST); Molecular epidemiology; Salivary gland carcinoma (SGC); Single nucleotide polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FAMILY HISTORY; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; RADIATION EXPOSURE; SALIVARY GLAND CARCINOMA;

NICOTIANA TABACUM;

EID: 65549165174     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806-816.
2. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg 1986;8:177-184.
3. Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 2005;63:917-928.
4. Belsky JL, Tachikawa K, Cihak RW, Yamamoto T. Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957 to 1970. JAMA 1972;219:864-868.
5. Whatley WS, Thompson JW, Rao B. Salivary gland tumors in survivors of childhood cancer. Otolaryngol Head Neck Surg 2006;134:385-388.
6. Zheng R, Wang LE, Bondy ML, Wei Q, Sturgis EM. Gamma radiation sensitivity and risk of malignant and benign salivary gland tumors: a pilot case-control analysis. Cancer 2004;100:561-567.
7. Raimondi AR, Vitale-Cross L, Amornphimoltham P, Gutkind JS, and Molinolo A. Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter. Am J Pathol 2006;168:1654-1665.
8. Ho T, Wei Q, Sturgis EM. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck 2007;29: 682-699.
9. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P, Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18:1285-1289.
10. Strange RC, Lear JT, Fryer AA. Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact 1998;111-112:351-364.
11. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005;221:123-129.
12. Cheng L, Sturgis EM, Eicher SA, Char D, Spitz MR, Wei Q. Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer 1999;84:220-224.
13. Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, Lazarus P, Oude Ophuis MB, Benhamou S, Foulkes WD, Katoh T, Coutelle C, Romkes M, Gaspari L, Taioli E, Boffetta P. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1509-1517.
14. Wang J, Deng Y, Cheng J, Ding J, Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003;201:185-193.
15. Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S,Alberg AJ, Watson M, Comstock GW, Bell D. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 1998;90:512-518.
16. Ezer R, Alonso M, Pereira E, Kim M, Allen JC, Miller DC, Newcomb EW. Identification of glutathione S-transferase polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J Neurooncol 2002;59:123-134.
17. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-743.
18. Firozi PF, Bondy ML, Sahin AA, Chang P, Lukmanji F, Singletary ES, Hassan MM, Li D. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis 2002; 23:301-306.
19. Millikan R, Pittman G, Tse CK, Savitz DA, Newman B, Bell D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9:567-573.
20. Eyfjord JE, Tryggvadottir L, Gudmundsdottir K. GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene. Cancer Epidemiol Biomarkers Prev 2001;10:1169-1173.
21. Ho T, Zhao C, Zheng R, Liu Z, Wei Q, Sturgis EM. Glutathione S-Transferase polymorphims and risk of differentiated thyroid carcinomas. Arch Otolaryngol Head Neck Surg 2006;132:756-761.
22. Patel BP, Rawal UM, Rawal RM, Shukla SN, Patel PS. Tobacco, antioxidant enzymes, oxidative stress and genetic susceptibility in oral cancer. Am J Clin Oncol 2008;31:454-459.
23. Kiran M, Chawla YK, and Kaur J. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India. DNA Cell Biol 2008;27:687-694.
24. Siraj AK, Ibrahim M, Al-Rasheed M, Abubaker J, Bu R, Siddiqui SU, Al-Dayel F, Al-Sanea O, Al-Nuaim A, Uddin S, Al-Kuraya K. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. BMC Med Genet 2008;9:61.
25. Yuan JM, Chan KK, Coetzee GA, Castelao JE, Watson MA, Bell DA, Wang R, Yu MC. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis 2008;29:1386-1393.